Enanta Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 3.73 M | $58.76 M | 91.57% | 12.97% |
| BLACKROCK, INC. | 02/12/2026 | 3.08 M | $48.51 M | 67.83% | 10.70% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 2.77 M | $43.72 M | 30.63% | 9.64% |
| VANGUARD GROUP INC | 01/29/2026 | 2.30 M | $36.30 M | 18.72% | 8.01% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 1.96 M | $30.86 M | 100.00% | 6.81% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 885.13 K | $13.95 M | 2.09% | 3.08% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 670.43 K | $10.57 M | -29.29% | 2.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 645.79 K | $10.19 M | 30.94% | 2.25% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 642.20 K | $10.13 M | 33.90% | 2.23% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/10/2026 | 422.30 K | $6.66 M | 100.00% | 1.98% |
| STATE STREET CORP | 02/13/2026 | 523.72 K | $8.26 M | 10.96% | 1.82% |
| 02/13/2026 | 389.69 K | $6.15 B | 100.00% | 1.36% | |
| MARSHALL WACE, LLP | 02/13/2026 | 385.28 K | $6.08 M | 39.90% | 1.34% |
| MORGAN STANLEY | 02/13/2026 | 339.92 K | $5.36 M | 20.27% | 1.18% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 285.45 K | $4.50 M | 370.09% | 0.99% |
| INVESCO LTD. | 02/19/2026 | 253.81 K | $4.00 M | 325.16% | 0.88% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 234.84 K | $3.70 M | 3.52% | 0.82% |
| NORTHERN TRUST CORP | 02/17/2026 | 229.89 K | $3.63 M | 17.35% | 0.80% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 218.82 K | $3.45 M | 31.47% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 218.64 K | $3.45 M | 31.28% | 0.76% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 211.61 K | $3.34 M | -21.64% | 0.74% |
| JPMORGAN CHASE & CO | 02/11/2026 | 112.96 K | $1.78 M | -8.77% | 0.53% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 143.30 K | $2.26 M | 14.55% | 0.50% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 103.90 K | $1.64 M | 34.06% | 0.36% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 100.00 K | $1.58 M | -67.21% | 0.35% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 99.88 K | $1.58 M | 403.96% | 0.35% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 99.40 K | $1.57 M | 252.48% | 0.35% |
| SEI INVESTMENTS CO | 02/13/2026 | 98.78 K | $1.56 M | 33.75% | 0.34% |
| CITADEL ADVISORS LLC | 02/17/2026 | 93.16 K | $1.47 M | 100.00% | 0.32% |
| NUVEEN, LLC | 02/12/2026 | 86.06 K | $1.36 M | -47.77% | 0.30% |
| OPALEYE MANAGEMENT INC. | 02/17/2026 | 75.00 K | $1.18 M | 100.00% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 72.59 K | $1.14 M | 19.99% | 0.25% |
| PDT PARTNERS, LLC | 02/17/2026 | 69.20 K | $1.09 M | -19.56% | 0.24% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 66.99 K | $1.06 M | 100.00% | 0.23% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 65.98 K | $1.04 M | 120.28% | 0.23% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 65.97 K | $1.04 M | 100.00% | 0.23% |
| DIADEMA PARTNERS LP | 02/17/2026 | 65.14 K | $1.03 M | 100.00% | 0.23% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 63.22 K | $996.96 K | 100.00% | 0.22% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 45.88 K | $723.48 K | -15.45% | 0.21% |
| BARCLAYS PLC | 02/13/2026 | 54.99 K | $867.18 K | 32.12% | 0.19% |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 02/12/2026 | 54.15 K | $853.93 K | 187.19% | 0.19% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 52.73 K | $831.52 K | 100.00% | 0.18% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/17/2026 | 50.43 K | $795.34 K | 0.00% | 0.18% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 41.36 K | $652.20 K | 100.00% | 0.14% |
| EAM INVESTORS, LLC | 02/12/2026 | 40.95 K | $645.81 K | 100.00% | 0.14% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 40.02 K | $631.04 K | 100.00% | 0.14% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 40.00 K | $630.80 K | 100.00% | 0.14% |
| THRIVENT FINANCIAL FOR LUTHERANS | 02/05/2026 | 28.38 K | $448.00 K | -16.64% | 0.13% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 37.48 K | $591.12 K | 10.68% | 0.13% |
| IEQ CAPITAL, LLC | 02/13/2026 | 36.39 K | $573.79 K | -3.45% | 0.13% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enanta Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 174 institutional investors and hedge funds held shares of Enanta Pharmaceuticals Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 3.08 M
VANGUARD GROUP INC: 2.3 M
Deep Track Capital, LP: 1.96 M
ACADIAN ASSET MANAGEMENT LLC: 885,126
MILLENNIUM MANAGEMENT LLC: 670,428
GEODE CAPITAL MANAGEMENT, LLC: 645,791
91.74% of Enanta Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 21.89 M shares in the last 24 months. This purchase volume represents approximately $295.69 M in transactions.